Two novel truncating mutations broaden the spectrum of prion amyloidosis.

Truncating mutations in have been associated with heterogeneous phenotypes ranging from chronic diarrhea and neuropathy to dementia, either rapidly or slowly progressive. We identified novel stop-codon mutations (p.Y163X, p.